"Researchers identified that Tlr5 gene mutations make mice more susceptible to idiopathic pulmonary fibrosis (IPF). Activating the TLR5 receptor in airway cells helps prevent lung fibrosis and improves survival in mice. The study suggests a potential new pathway for treating IPF, a disease currently lacking a cure. Future research will focus on validating these findings in humans and developing inhaled treatments."